Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vistagen Therapeutics (VTGN) Change in Receivables (2019 - 2021)

Vistagen Therapeutics' Change in Receivables history spans 6 years, with the latest figure at $3400.0 for Q4 2021.

  • For Q4 2021, Change in Receivables changed N/A year-over-year to $3400.0; the TTM value through Sep 2021 reached -$3400.0, changed N/A, while the annual FY2021 figure was $40600.0, 113.53% up from the prior year.
  • Change in Receivables for Q4 2021 was $3400.0 at Vistagen Therapeutics, up from -$40600.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $1.2 million in Q1 2018 and bottomed at -$300000.0 in Q2 2019.
  • The 3-year median for Change in Receivables is $0.0 (2021), against an average of $158333.3.